课题基金 / 基金详情

Schizophrenia as a genomic disorder

Schizophrenia as a genomic disorder
精神分裂症是一种基因组疾病
批准号：
179678
负责人：
Bassett Anne S
金额：
$68.11万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=179678&lang=en
关键词：
22q11 Deletion Syndrome Genetic Syndrome Genetics Schizophrenia

项目摘要

项目成果

Bassett Anne S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Schizophrenia is a serious psychiatric illness that affects 1 in 100 people. In schizophrenia, 1 in 100 people have a genetic syndrome called 22q11.2 Deletion Syndrome (22qDS) that is associated with a 22q11.2 deletion (piece missing from a region on one
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Outcomes and disease burden in a model of young adult multimorbidity
Outcomes and disease burden in a model of young adult multimorbidity
Impact of tandem repeat expansions in schizophrenia
Determining genetic and non-genetic risk for schizophrenia in a high risk group
海外基金